Effective Half‐Life in Clinical Pharmacology

The Journal of Clinical PharmacologyVolume 35, Issue 8 p. 763-766 Effective Half-Life in Clinical Pharmacology Dr. Harold Boxenbaum PhD, Dr. Harold Boxenbaum PhD Wyeth-Ayerst Research, Philadelphia, Pennsylvania Otsuka America Pharmaceutical, Inc., Rockville, MarylandSearch for more papers by this authorMichele Battle PhD, Corresponding Author Michele Battle PhD Wyeth-Ayerst Research, Philadelphia, PennsylvaniaWyeth-Ayerst Research, P.O. Box 8299, Philadelphia, PA 19101Search for more papers by this author Dr. Harold Boxenbaum PhD, Dr. Harold Boxenbaum PhD Wyeth-Ayerst Research, Philadelphia, Pennsylvania Otsuka America Pharmaceutical, Inc., Rockville, MarylandSearch for more papers by this authorMichele Battle PhD, Corresponding Author Michele Battle PhD Wyeth-Ayerst Research, Philadelphia, PennsylvaniaWyeth-Ayerst Research, P.O. Box 8299, Philadelphia, PA 19101Search for more papers by this author First published: August 1995 https://doi.org/10.1002/j.1552-4604.1995.tb04117.xCitations: 90AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume35, Issue8August 1995Pages 763-766 RelatedInformation